Investment
Features
FeesSafety
Academy
More
Pluang+

Compare i-80 Gold Corp. Common Shares (IAUX) vs Tempus AI (TEM) Price & Performance

i-80 Gold Corp. Common SharesTrade

Price performance (Past 24H)

Key statistics

i-80 Gold Corp. Common Shares vs Tempus AI — how do they compare? i-80 Gold Corp. Common Shares trades at $1.45 (market cap $1.34B), while Tempus AI trades at $67.03 (market cap $12.39B). The key difference: Tempus AI is far larger — about 9.2× i-80 Gold Corp. Common Shares's market cap, and Tempus AI is more actively traded (4,141,569 versus 3,239,725). Which is the better fit depends on your goals — on Pluang, investors hold i-80 Gold Corp. Common Shares for 0 Days and Tempus AI for 23 Days on average.

IAUXTEM
Market Cap
$1.34B$12.39B
Volume
3,239,7254,141,569
Sector
Basic MaterialsBroad Market / Factor
52-Week High
$2.08$92.45
52-Week Low
$0.89$41.55
Typical Hold Time
0 Days23 Days
Enterprise Value
$1.32B$13.01B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

i-80 Gold Corp. Common Shares

IAUX trades at $1.54, down 2.53% today, with a neutral technical signal. The company shows significant financial challenges with a -198.82% net income margin and negative ROE of -71.66%, though revenue grew from $95M in 2025 to $130M in 2026. Recent positive developments include CEO purchasing 1 million shares and feasibility studies showing strong potential for Nevada gold projects. Analyst consensus remains unanimously bullish with 3 buy ratings.

While facing substantial profitability challenges, IAUX's development pipeline and CEO confidence suggest long-term potential. Key risks include persistent negative cash flow from operations and high debt levels. The stock presents a high-risk, high-reward opportunity dependent on successful project execution and gold price stability.

Tempus AI

Tempus AI (TEM) trades at $68.22, up 0.34% with a bullish technical signal despite negative profitability. The stock shows strong analyst support with 64% buy ratings and a $72.60 consensus target. Recent FDA clearance for ECG-MR AI product and ESMO conference presentations highlight ongoing innovation, while Q2 2026 earnings beat expectations with 22% revenue growth. Cash flow remains positive primarily from financing activities.

While TEM demonstrates strong revenue growth and product innovation, significant risks persist including negative net margins (-17.77%) and substantial insider selling. The stock's high P/B ratio of 27.84 suggests premium valuation despite unprofitability. Near-term catalysts include Q3 earnings and ESMO presentations, but investors should weigh growth potential against persistent losses and competitive pressures in AI healthcare.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IAUX
100% Buy0% Sell
Avg holding period · 0 Days
TEM
28% Buy72% Sell
Avg holding period · 23 Days

Top news

Latest headlines on both assets

About i-80 Gold Corp. Common Shares

i-80 Gold Corp. is a mining company focused on developing and operating gold and precious-metals projects in Nevada, using a hub-and-spoke model centered on a processing facility to support multiple mine sites in the state.

Read more on IAUX →

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM →